Arm Forecast, price target & analysts
Arm Target price 2025 - Analyst rating & recommendation
Arm Classifications & Recommendation:
Arm Price Target
| Target Price | $139.94 |
| Price | $133.11 |
| Potential | 5.13% |
| Number of Estimates | 31 |
| 31 Analysts have issued a price target Arm 2026 . The average Arm target price is $139.94. This is 5.13% higher than the current stock price. The highest price target is $180.00 35.23% , the lowest is $80.00 39.90% . | |
| A rating was issued by 38 analysts: 24 Analysts recommend Arm to buy, 12 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Arm stock has an average upside potential 2026 of 5.13% . Most analysts recommend the Arm stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2030
33 Analysts have issued a sales forecast Arm 2026 . The average Arm sales estimate is $4.8b . This is 19.00% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $5.0b 24.16% , the lowest is $4.6b 14.73% .
This results in the following potential growth metrics:
Revenue Estimates
| 2025 | $4.0b | 23.94% |
|---|---|---|
| 2026 | $4.8b | 19.00% |
| 2027 | $5.8b | 22.28% |
| 2028 | $7.0b | 19.27% |
| 2029 | $8.0b | 15.12% |
| 2030 | $9.3b | 16.50% |
19 Analysts have issued an Arm EBITDA forecast 2026. The average Arm EBITDA estimate is $2.3b . This is 123.91% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.6b 157.89% , the lowest is $1.4b 35.70% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2025 | $1.0b | 414.72% |
|---|---|---|
| 2026 | $2.3b | 123.91% |
| 2027 | $2.9b | 27.89% |
| 2028 | $4.1b | 40.05% |
| 2029 | $4.3b | 5.50% |
| 2030 | $5.0b | 17.65% |
EBITDA Margin
| 2025 | 25.31% | 315.30% |
|---|---|---|
| 2026 | 47.61% | 88.14% |
| 2027 | 49.79% | 4.58% |
| 2028 | 58.47% | 17.43% |
| 2029 | 53.58% | 8.36% |
| 2030 | 54.11% | 0.99% |
19 Arm Analysts have issued a net profit forecast 2026. The average Arm net profit estimate is $1.1b . This is 37.56% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.7b 110.87% , the lowest is $328m 58.63% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2025 | $792m | 158.82% |
|---|---|---|
| 2026 | $1.1b | 37.56% |
| 2027 | $1.7b | 56.17% |
| 2028 | $2.3b | 37.48% |
| 2029 | $3.1b | 33.30% |
| 2030 | $3.8b | 22.54% |
Net Margin
| 2025 | 19.77% | 108.83% |
|---|---|---|
| 2026 | 22.85% | 15.61% |
| 2027 | 29.18% | 27.70% |
| 2028 | 33.63% | 15.25% |
| 2029 | 38.95% | 15.82% |
| 2030 | 40.97% | 5.19% |
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
19 Analysts have issued a Arm forecast for earnings per share. The average Arm EPS is $1.03 . This is 37.33% higher than earnings per share in the financial year 2025. The highest EPS forecast is $1.58 110.67% , the lowest is $0.31 58.67% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2025 | $0.75 | 158.62% |
|---|---|---|
| 2026 | $1.03 | 37.33% |
| 2027 | $1.61 | 56.31% |
| 2028 | $2.21 | 37.27% |
| 2029 | $2.95 | 33.48% |
| 2030 | $3.62 | 22.71% |
P/E ratio
| Current | 177.48 | 58.77% |
|---|---|---|
| 2026 | 129.15 | 27.23% |
| 2027 | 82.70 | 35.97% |
| 2028 | 60.15 | 27.27% |
| 2029 | 45.12 | 24.99% |
| 2030 | 36.82 | 18.40% |
Current Arm Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Loop Capital |
Buy
➜
Buy
|
Unchanged | May 13 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | May 08 2025 |
| Benchmark |
Hold
➜
Hold
|
Unchanged | May 08 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | May 08 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | May 08 2025 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | May 08 2025 |
| Guggenheim |
Buy
➜
Buy
|
Unchanged | May 08 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Loop Capital:
Buy
➜
Buy
|
May 13 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
May 08 2025 |
|
Unchanged
Benchmark:
Hold
➜
Hold
|
May 08 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
May 08 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 08 2025 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
May 08 2025 |
|
Unchanged
Guggenheim:
Buy
➜
Buy
|
May 08 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
